Inventor · disambiguated record
George Shlieout
Also filed as: SHLIEOUT GEORGE
4 granted patents·19 pending applications·5 citations·filing 2005–2025
66Inventor score
Top patents by PatentIndex Score
23 records- 0178US9198871B2Delayed release pancreatin compositionsSHLIEOUT GEORGE·Filed 2006·Granted Dec 1, 2015·3 cites·32 claims
- 0274US2024424070A1Enzyme compositions with reduced viral and microbial contaminationABBVIE INC·Filed 2024·Application pending·0 cites
- 0370US2025345405A1Enzyme compositions with reduced viral and microbial contaminationABBVIE INC·Filed 2025·Application pending·0 cites
- 0468US8802087B2Pharmaceutical compositions of lipase-containing products, in particular of pancreationSHLIEOUT GEORGE·Filed 2005·Granted Aug 12, 2014·2 cites·43 claims
- 0568US2021353722A1Controlled release pharmaceutical compositions for acid-labile drugsAbbVie Pharmaceuticals GmbH·Filed 2021·Application pending·0 cites
- 0666US2019247473A1Controlled release pharmaceutical compositions for acid-labile drugsABBOTT PRODUCTS GMBH·Filed 2019·Application pending·0 cites
- 0766US2022211825A1Enzyme compositions with reduced viral and microbial contaminationABBVIE INC·Filed 2022·Application pending·0 cites
- 0866US2021060142A1Controlled release pharmaceutical compositions for acid-labile drugsAbbVie Pharmaceuticals GmbH·Filed 2020·Application pending·0 cites
- 0966US2024148660A1Process for the manufacture and use of pancreatin micropellet coresAbbVie Pharmaceuticals GmbH·Filed 2024·Application pending·0 cites
- 1061US2014065232A1Controlled release pharmaceutical compositions for acid-labile drugsABBOTT PRODUCTS GMBH·Filed 2013·Application pending·0 cites
- 1159US11278603B2Enzyme compositions with reduced viral and microbial contaminationABBVIE INC·Filed 2017·Granted Mar 22, 2022·0 cites·35 claims
- 1259US2025152683A1Processes for producing compositions with improved safety profile having lipase activity and compositions suitable for pharmaceutical useABBVIE INC·Filed 2025·Application pending·0 cites
- 1358US2022183988A1Process for the manufacture and use of pancreatin micropellet coresAbbVie Pharmaceuticals GmbH·Filed 2022·Application pending·0 cites
- 1456US11266607B2Process for the manufacture and use of pancreatin micropellet coresSHLIEOUT GEORGE·Filed 2006·Granted Mar 8, 2022·0 cites·101 claims
- 1556US2016263201A1Controlled release pharmaceutical compositions for acid-labile drugsABBOTT PRODUCTS GMBH·Filed 2016·Application pending·0 cites
- 1655US2024226249A9Controlled release pharmaceutical compositions for acid-labile drugsAbbVie Pharmaceuticals GmbH·Filed 2023·Application pending·0 cites
- 1755US2016095906A1Controlled release pharmaceutical compositions for acid-labile drugsABBOTT PRODUCTS GMBH·Filed 2015·Application pending·0 cites
- 1850US2019201502A1Enzyme compositions with reduced viral and microbial contaminationABBVIE INC·Filed 2019·Application pending·0 cites
- 1949US2019275122A1Pharmaceutical compositions of lipase-containing products, in particular of pancreatinABBOTT PRODUCTS GMBH·Filed 2019·Application pending·0 cites
- 2049US2014302000A1Pharmaceutical compositions of lipase-containing products, in particular of pancreatinABBOTT PRODUCTS GMBH·Filed 2014·Application pending·0 cites
- 2148US2019151425A1Processes for producing compositions with improved safety profile having lipase activity and compositions suitable for pharmaceutical useSHLIEOUT GEORGE·Filed 2019·Application pending·0 cites
- 2242US2011008423A1Pharmaceutical compositions comprising granules of purified microbial lipase and methods for preventing or treating digestive disordersABBOTT PRODUCTS GMBH·Filed 2009·Application pending·0 cites
- 2339US2016120964A1Processes for producing compositions with improved safety profile having lipase activity and compositions suitable for pharmaceutical useSHLIEOUT GEORGE·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when George Shlieout files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →